{{Infobox disease |
  Name           = Arteritis |
  ICD10          = {{ICD10|I|77|6|i|70}}, {{ICD10|M|31| |m|30}} |
  ICD9           = {{ICD9|447.6}} | 
  Image          = |
  Caption        = |
  DiseasesDB     = 13750 |
  ICDO           = |
  OMIM           = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  MeshID         = D001167 |
}}
{{Distinguish|arthritis}}
'''Arteritis''' is the [[inflammation]] of the walls of [[artery|arteries]],<ref>{{DorlandsDict|one/000008435|Arteritis}}</ref> usually as a result of [[infection]] or [[auto-immune]] response. Arteritis is a complex disorder that is still not completely understood in entirety.<ref>{{cite journal|last=Hollier|first=L. H.|title=Arteritis|journal=Perspectives in Vascular Surgery and Endovascular Therapy|date=1 January 1989|volume=2|issue=1|pages=1–8|doi=10.1177/153100358900200101}}</ref>  Arteritis may be distinguished by its different types, based on the organ systems that are affected by the disease.<ref>{{cite journal|last=Hollier|first=L. H.|title=Arteritis|journal=Perspectives in Vascular Surgery and Endovascular Therapy|date=1 January 1989|volume=2|issue=1|pages=1–8|doi=10.1177/153100358900200101}}</ref> 


==Types==
Some disorders have arteritis as their main feature. The major types are given in the table below:
{| class="wikitable"
|-
!colspan=3| Comparison of major types of arteritis
|-
! Arteritis !! Affected organs !! [[Histopathology]]
|-
| [[Takayasu's arteritis]] || Large vessels<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref>, including Aorta and [[Aortic arch|arch]] branches<ref name=Fleshandbones>Stevens & Lowe: Pathology. At Fleshandbones.com</ref> || Histiocytes, giant cells<ref name=Fleshandbones/>
|-
| [[Giant cell arteritis]], also often called ''temporal arteritis'' (although these differ slightly) || [[superficial temporal artery]], other medium- and large-sized vessels,<ref name=emedicine>[http://emedicine.medscape.com/article/809492-overview eMedicine Specialties > Temporal Arteritis] Author: Christopher H Lee, MD. Coauthor(s): Jean Marie Hammel, MD. Updated: Sep 8, 2009</ref> e.g. the ones supplying the [[head]], [[human eye|eye]]s and [[optic nerve]]s || Lymphocytes, macrophages, and multinucleated [[giant cell]]s<ref name=emedicine/>
|-
| [[Polyarteritis nodosa]] || [[central nervous system|CNS]], [[Peripheral neuropathy|PNS damage]], kidneys, [[gastrointestinal tract|GI tract]], [[skeletal muscle]], heart<ref name=Fleshandbones/> || [[Neutrophil]]s, [[fibrinoid necrosis]]<ref name=Fleshandbones/>
|}

Furthermore, there are many conditions that have vasculitis as an accompanying or atypical symptom, including arteritis caused by the fungal pathogen ''[[Candida albicans]]''.<ref>{{cite journal |author=Nagi-Miura N |title=Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction |journal=Atherosclerosis |volume=186 |issue=2 |pages=310–20 |year=2006 |month=Jun |pmid=16157343 |doi=10.1016/j.atherosclerosis.2005.08.014 |url= |author-separator=, |author2=Harada T |author3=Shinohara H |display-authors=3 |last4=Kurihara |first4=Kiyoshi |last5=Adachi |first5=Yoshiyuki |last6=Ishida-Okawara |first6=Akiko |last7=Oharaseki |first7=Toshiaki |last8=Takahashi |first8=Kei |last9=Naoe |first9=Shiro}}</ref>

'''Giant Cell Arteritis''' 

Giant cell arteritis contain two different types of artertides that are almost scientifically  indistinguishable from one another.<ref>{{cite journal|last=Hollier|first=L. H.|title=Arteritis|journal=Perspectives in Vascular Surgery and Endovascular Therapy|date=1 January 1989|volume=2|issue=1|pages=1–8|doi=10.1177/153100358900200101}}</ref>  Giant cell arteritis includes two types, these are Temporal arteritis and Takayasu’s arteritis. Both of these types contain an occupancy of medium and larger size arteries which are categorized based on the infiltration of the giant cells.<ref>{{cite journal|last=Hollier|first=L. H.|title=Arteritis|journal=Perspectives in Vascular Surgery and Endovascular Therapy|date=1 January 1989|volume=2|issue=1|pages=1–8|doi=10.1177/153100358900200101}}</ref> 

'''Takayasu Arteritis'''

This type of arteritis is found to be most common in females with a median age of 25 years.<ref>{{cite journal|last=Kerr|first=Gail S.|coauthors=Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman|title=Takayasu Arteritis. Annals of Internal Medicine.|year=1994|month=June|volume=120|issue=11|pages=919-929}}</ref>  Takayasu arteritis is also most common in women of Asian descent that are in their reproductive years.<ref>{{cite journal|last=Kerr|first=Gail S.|coauthors=Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman|title=Takayasu Arteritis. Annals of Internal Medicine.|year=1994|month=June|volume=120|issue=11|pages=919-929}}</ref>  However, over the past decades, Takayasu arteritis patients are increasing in Africa, Europe, and North America.<ref>{{cite journal|last=Kerr|first=Gail S.|coauthors=Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman|title=Takayasu Arteritis. Annals of Internal Medicine|year=1994|month=June|volume=120|issue=11|pages=919-929}}</ref>  Takayasu’s arteritis is an inflammatory disease that mainly affects the larger vessels such as the aorta and its surrounding branches.<ref>{{cite journal|last=Kerr|first=Gail S.|coauthors=Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman|title=Takayasu Arteritis. Annals of Internal Medicine|year=1994|month=June|volume=120|issue=11|pages=919-929}}</ref>  Research of Takayasu arteritis in the Western parts of the world still remain limited. An estimation suggests that each year, the rate of cases in a million people is 2.6.<ref>{{cite journal|last=Kerr|first=Gail S|coauthors=Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman|title=Takayasu Arteritis. Annals of Internal Medicine|year=1994|month=June|volume=120|issue=11|pages=919-929}}</ref> 

'''Temporal Arteritis'''

Temporal Arteritis, the second type of giant cell arteritis, is also a chronic, inflammatory disease that involves the middle to larger sized arteries.<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref>  Most commonly, Temporal Arteritis incidents were found in Scandinavian descents, this includes Scandinavian Americans as well.<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref>  However, the incidence rate differs based on population, region and races.<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref>  Temporal Arteritis is not uncommon in North America either.<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref>  The incidence rate is around 0.017% for individuals over 50 years of age.<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref> 

Most Common symptoms of Temporal arteritis are based on specific and nonspecific indications.<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref> 

Non specific symptoms<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref> : 
* Headache 
* Low grade fever 
* Sweating 
* Anorexia 
* Weight loss 
* General malaise 
Specific symptoms<ref>{{cite journal|last=Chen|first=Chun-Hsiung|coauthors=Kung, Shih-Ya; Tsai, Ying-Yang; Liao, Hsien-Tzung; Chou, Chung-Tei; Huang, De-Feng|title=Temporal Arteritis|journal=Journal of the Chinese Medical Association|date=NaN undefined NaN|volume=68|issue=7|pages=333–335|doi=10.1016/S1726-4901(09)70170-4}}</ref> :
* Claudication of the jaw
* Engorged tender vessels
Specific symptoms are usually are developed in the advanced stages of Temporal artieritis.<ref>{{cite journal|doi=10.1016/S1726-4901(09)70170-4}}</ref>

==Symptoms==
Symptoms of general arteritis may include<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref>:
* inflammation
* fever
* increased production of red blood cells (erythrocyte)
* limping
* reduced pulse

==Diagnosis==

Diagnosis of Arteritis is based on unusual medical symptoms.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  At this time, conditions should be distinguished between similar symptoms such as, Ehlers-Danlos and Marfan syndrome, tuberculosis, syphilis, spondyloarthopathies, Cogans’s syndrome, Buerger’s, Behcet’s, and Kawasaki disease.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  There are several diagnoses approaches that can be used. For example, imaging techniques such as angiography, computer tomography angiography (CTA), magnetic resonance angiography (MRA), and ultrasonography, are being used not only for the diagnosis of arteritis, but additionally to help monitor the disease.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref> 

'''Angiography'''

Angiography is commonly used for the diagnosis of Takayasu’s arteritis.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  Especially in the advanced stages when artery stenosis, occlusion, aneurysm formation occurs, and so forth.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  However, angiography is an aggressive examination, where patients receive large doses of radition. <ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref> Therefore, it is not recommended for long term patients of Takayasu arteritis.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref> 

'''CTA'''

CTA can determine the lumen of aorta and the surrounding branches, and identify vessel wall lesions in middle to advanced stages of arteritis.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  CTA diagnosis can also display the intravascular blood flow.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  Similar to angiography, CTA also requires patients to take high dosages of radiation. <ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref> 

'''MRA'''

MRA is used to diagnose early stages of Takayasu’s arteritis, such as the thickening of the vessel wall.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  MRA also includes clear pictures of how thick the vessel wall is becoming.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  Disadvantages of MRA are that it is a very expensive procedure, and may produce poor images for distal branches and aortic calcification.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref> 

'''Ultrasonography'''

Ultrasonography is an ideal method of diagnosing patients in early stages of arteritis when there is inflammation in the vessel walls.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  This method also shows the blood flow that occurs in the vessel. <ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref> Ultrasonography has become an ideal method for diagnosis because it is non- invasive.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>  It is also commonly used for long term monitoring in Takayasu’s arteritis. Disadvantages of this method are its difficulties to identify some vascular lesions, and also, the operative’s skill affects the reliability of the results.<ref>{{cite journal|last=Wen|first=Dan|coauthors=Du, Xin; Ma, Chang-Sheng|title=Takayasu Arteritis: Diagnosis, Treatment and Prognosis|journal=International Reviews of Immunology|date=1 December 2012|volume=31|issue=6|pages=462–473|doi=10.3109/08830185.2012.740105}}</ref>

==Treatment Methods==
===Medications===
Those suffering from arteritis are first treated with an oral drug, known as gluccorticoids, daily for a period of three months.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref> Prednisone may also be used for treatment, instead of gluccorticoids.<ref>{{cite journal|last=Hollier|first=L. H.|title=Arteritis|journal=Perspectives in Vascular Surgery and Endovascular Therapy|date=1 January 1989|volume=2|issue=1|pages=1–8|doi=10.1177/153100358900200101}}</ref> After 3 months, treatment will become bi-daily, if possible.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref> If disease worsens with new treatment schedule, a cytotoxic agent will be given, in addition to gluccorticoids.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref> The cytotoxic agent may be azathioprine, methotrexate, or cyclophosphamide.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref> If the patient begins to recover, the dosage of gluccorticoids is decreased.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref> When disease becomes inactive in the patient, the dosage of drugs will be further reduced, until it is stopped.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref> Conversely, if disease is still active, the dosage of drugs will be increased.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref> If the drugs cannot be reduced to bi-daily consumption, in six months of the treatment or the drugs are not cut off completely within twelve months, then treatment deemed to be a failure.<ref>Gail S. Kerr, Claire W. Hallahan, Joseph Giordano, Randi Y. Leavitt, Anthony S. Fauci, Menachem Rottem, Gary S. Hoffman; Takayasu Arteritis. Annals of Internal Medicine. 1994 Jun;120(11):919-929.</ref>

===Therapy===
Therapy is another method of treatment for those with arteritis.<ref>{{cite journal|title=Arteritis|journal=Arthritis & Rheumatism|date=1 February 1981|volume=24|issue=2|pages=192–196|doi=10.1002/art.1780240217}}</ref> Pulse therapy is done with steroids such as corticosteroids, and this method has proven to be successful for some who suffered arteritis.<ref>{{cite journal|title=Arteritis|journal=Arthritis & Rheumatism|date=1 February 1981|volume=24|issue=2|pages=192–196|doi=10.1002/art.1780240217}}</ref> Immunosuppresive therapy has also proven to cure people of this disease.<ref>{{cite journal|last=Bose|first=P.|title=TAKAYASU'S ARTERITIS|journal=Journal of Neurology, Neurosurgery & Psychiatry|date=29 November 2012|volume=83|issue=Suppl 2|pages=A1–A1|doi=10.1136/jnnp-2012-304200a.2}}</ref>

==References==
{{reflist}}

{{Vascular diseases}}
{{Systemic connective tissue disorders}}
{{Inflammation}}

[[Category:Systemic connective tissue disorders]]
[[Category:Diseases of arteries, arterioles and capillaries]]
[[Category:Inflammations]]

{{disease-stub}}